Stereotaxis (STXS) Gains from Investment Securities (2011 - 2026)
Stereotaxis (STXS) reported Gains from Investment Securities of $1000.0 for Q1 2026, down 99.08% year-over-year from $108255.0 in Q1 2025, and down 99.72% quarter-over-quarter from $361000.0 in Q4 2025.
Stereotaxis (STXS) Gains from Investment Securities (2011 - 2026) Analysis & Trends
Stereotaxis (STXS) has 16 years of Gains from Investment Securities data on file, last reported at $1000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $1000.0, down 99.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $1000.0 (down 99.08% YoY), and the FY2025 annual result was $4.3 million, up 10.68% from the prior year.
- Gains from Investment Securities declined to $1000.0 in Q1 2026 per STXS's latest filing, from $361000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $152.9 million in Q2 2022 and troughed at $1000.0 in Q1 2026.
- A 5-year average of $10.1 million and a median of $697000.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2026: Gains from Investment Securities surged 5272.96% in 2022, then plunged 99.08% in 2026.
- A 5-year view of Gains from Investment Securities shows it stood at $3.2 million in 2022, then gained by 13.78% to $3.7 million in 2023, then tumbled by 69.15% to $1.1 million in 2024, then sank by 67.94% to $361000.0 in 2025, then plunged by 99.72% to $1000.0 in 2026.
- Business Quant data shows STXS's Gains from Investment Securities at $1000.0 in Q1 2026, $361000.0 in Q4 2025, and $170658.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Stereotaxis | 180.48 Mn | 165.86 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 361,000.00 |
| Dec 31, 2025 | 361,000.00 |
| Sep 30, 2025 | 170,658.00 |
| Sep 30, 2025 | 170,658.00 |
| Jun 30, 2025 | 135,720.00 |
| Jun 30, 2025 | 135,720.00 |
| Mar 31, 2025 | 108,255.00 |
| Mar 31, 2025 | 108,255.00 |
| Dec 31, 2024 | 1.13 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 728,500.00 |
| Sep 30, 2024 | 728,500.00 |
| Jun 30, 2024 | 251,005.00 |
| Jun 30, 2024 | 251,005.00 |
| Mar 31, 2024 | 189,832.00 |
| Mar 31, 2024 | 189,832.00 |
| Dec 31, 2023 | 3.65 Mn |
| Dec 31, 2023 | 3.65 Mn |